Skip to content

Wave Life Sciences WVE Q4 2024 Annual earnings

Reported March 4, 2025 · Before market open

Revenue$83.7MBeat by $71.6M
EPS$0.17Beat by $0.34
Revenue estimate$12.2M
EPS estimate-$0.17

Next report

Jul 30, 2026 (Tomorrow)
Revenue estimate$7.4M
EPS estimate-$0.31

Financials

Q4 2024

Balance sheet

See full
Cash & equivalents$302.1M+50.8%
Total debt$25.4M-20.9%
Total equity$209.5M+429%
Total assets$352.2M+28.1%

Cash flow

See full
Operating cash flow-$43.6M-31.3%
CapEx$86.0K-75.8%
Free cash flow-$43.7M-30.2%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$1.89B+241%
Enterprise value$1.61B+318%

Returns & leverage

See full
Debt / equity0.1×-0.7×
Current ratio2.9×+1.6×

Versus estimates

Ask the moment Wave Life Sciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Wave Life Sciences report Q4 2024 earnings?
Wave Life Sciences (WVE) reported Q4 2024 earnings on March 4, 2025 before market open.
What were Wave Life Sciences's Q4 2024 revenue and EPS?
Wave Life Sciences reported revenue of $83.7M and eps of $0.17 for Q4 2024.
Did Wave Life Sciences beat estimates in Q4 2024?
Revenue beat the consensus estimate of $12.2M by $71.6M. EPS beat the consensus estimate of $-0.17 by $0.34.
Where can I find Wave Life Sciences's Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-031322) directly on SEC EDGAR. The filing index links above go to sec.gov.